1
2
3
4
5
6
7
8
9
10
J. Elaine-Marie Albert, MD, MHA
Seattle Children's Hospital
Appointed from nominations submitted by the speaker of the State House of Representatives per RCW 43.348.020 (1)(e)
Cliff Berkman, PhD
Washington State University
Appointed from nominations submitted by the president of Washington State University per RCW 43.348.020 (1)(a)
David Byrd, MD (Board Chair)
University of Washington
Appointed from nominations submitted by the president of the University of Washington per RCW 43.348.020 (1)(a)
Thomas Brown, MD, MBA (Board Treasurer)
Syapse
Nominations provided by private sector donors to the Fund per RCW 43.348.020 (1)(h)
Marc Cummings
Life Science Washington
Appointed from nominations submitted by representatives of business or industries engaged in the commercialization of life sciences research or cancer research per RCW 43.348.020 (1)(d)
Steven Harr, MD
Sana Biotechnology
Appointed from nominations provided by the president of the State Senate per RCW 43.348.020 (1)(f)
Gary S. Kaplan, MD, FACP, FACMPE, FACPE
Virginia Mason Franciscan Health
Appointed from nominations submitted by entities or systems that provide health care delivery services per RCW 43.348.020 (1)(g)
Elizabeth Lawlor, MD, PhD (Board Vice Chair)
Seattle Children’s Research Institute
Appointed from nominations submitted by the Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, and the Seattle Children's Research Institute per RCW 43.348.020 (1)(b)
Maura Little
Echo Health Ventures
Appointed from nominations to appoint a member of the public per RCW 43.348.020 (1)(i)
Karin Rodland, PhD
Pacific Northwest National Laboratory
Appointed from nominations submitted by representatives of businesses or industries engaged in the commercialization of life sciences research or cancer research per RCW 43.348.020 (1)(d)